Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking
NCT ID: NCT03668769
Last Updated: 2024-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2017-03-27
2020-03-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of a Smartphone Mobile Application (App) to Enhance Smoking Cessation Treatment
NCT03519451
Smartphone-delivered Scheduled Smoking With Compliance Facilitation as an Adjunct Cessation Therapy: a Feasibility Study
NCT05763771
Smartphone Application Smoking Cessation Study
NCT04623736
Trial of An Innovative Smartphone Intervention for Smoking Cessation
NCT02724462
Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer
NCT01457469
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To adapt the internal algorithms of the scheduled reduced smoking approach in Computer Assisted Stop Smoking Intervention for the World Wide Web (WebCASSI) into a smartphone application (app): Quitting Schedule.
II. Once the smartphone app is developed, a pretesting phase with smoker seeking care at MDACC Tobacco Treatment Program or another community service such as Equality Texas, Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) Advisory Board of the City of Houston, Montrose Center, Avenue 360 and Lesbian Health Initiative will follow.
III. To culturally and linguistically adapt Quitting Schedule app into Spanish language.
IV. To implement a feasibility trial in IDC (Colombia), INCan (Mexico), and INEN (Peru).
OUTLINE:
AIM I: Participants follow an individually tailored gradual reduction of smoking schedule for 5 weeks while MDACC eHealth adapts WebCASSI into a smartphone app: Quitting Schedule.
AIM II: Participants pre-test the Quitting Schedule mobile smartphone app for 5 weeks.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prevention (smoking reduction, Quitting Schedule mobile app)
AIM I: Participants follow an individually tailored gradual reduction of smoking schedule for 5 weeks while MDACC eHealth adapts WebCASSI into a smartphone app: Quitting Schedule.
AIM II: Participants pre-test the Quitting Schedule mobile smartphone app for 5 weeks.
Internet Mobile Technology
Use Quitting Schedule mobile smartphone app
Interview
Ancillary studies
Questionnaire Administration
Ancillary studies
Smoking Cessation Intervention
Participate in individual smoking cessation program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Internet Mobile Technology
Use Quitting Schedule mobile smartphone app
Interview
Ancillary studies
Questionnaire Administration
Ancillary studies
Smoking Cessation Intervention
Participate in individual smoking cessation program
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female (Aim 2)
* Adult cancer patients - 18 years or older (Aim 2)
* Current smokers seeking care at the Tobacco Treatment Program at MD Anderson and at Houston area community services who have smoked at least 100 cigarettes in lifetime
* Willing to download and use the app Quitting Schedule (Aim 2)
* Willing to set a quit smoking date within 5 weeks of the enrollment (Aim 2)
* Ownership of an iPhone or Android smartphone (Aim 2)
Exclusion Criteria
* Enrolled in another cessation program (Aim 2)
* Current use of NRT or other smoking cessation medications,e.g. Varenicline or Bupropion outside of the MD Anderson Institution (Aim 2)
* Expired CO levels below 7ppm (Aim 2)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul Cinciripini
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Related Links
Access external resources that provide additional context or updates about the study.
MD Anderson Cancer Center Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2018-01820
Identifier Type: REGISTRY
Identifier Source: secondary_id
2016-0516
Identifier Type: OTHER
Identifier Source: secondary_id
2016-0516
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.